|
| related topics |
| {customer, product, revenue} |
| {product, candidate, development} |
| {product, liability, claim} |
| {product, market, service} |
| {regulation, change, law} |
| {property, intellectual, protect} |
| {personnel, key, retain} |
| {acquisition, growth, future} |
| {cost, regulation, environmental} |
| {stock, price, share} |
|
|
If our revenues from sales of Acthar decline or fail to grow, we may not have sufficient revenues to fund our operations.
We have little or no control over our wholesalers buying patterns, which may impact future revenues and returns and may result in excess inventory.
If we are unable to contract with third party contract manufacturers, we may be unable to meet the demand for our products and lose potential revenues.
If our third party distributors are unable to distribute our products or the costs to distribute our products increase substantially, we will lose potential revenues and profits.
The loss of our key management personnel could have an adverse impact on future operations.
We are subject to numerous governmental regulations and it can be costly to comply with these regulations and to develop compliant products and processes.
Products that we may acquire or develop may not be accepted by the market, which may result in lower future revenues as well as a decline in our competitive positioning.
If competitors develop and market products that are more effective than ours, our commercial opportunity will be reduced or eliminated.
If we fail to maintain or enter into new contracts related to collaborations and in-licensed or acquired technology and products, our product development and commercialization could be delayed.
If we are unable to protect our proprietary rights, we may lose our competitive position and future revenues.
Our ability to generate revenues is affected by the availability of reimbursement on our products, and our ability to generate revenues will be diminished if we fail to obtain an adequate level of reimbursement for our products from third party payors.
Our business is subject to changing regulation of corporate governance and public disclosure that has increased both our costs and the risk of noncompliance.
If product liability lawsuits are successfully brought against us or we become subject to other forms of litigation, we may incur substantial liabilities and costs and may be required to limit commercialization of our products.
Risks Related to our Common Stock
We may seek additional funding which would dilute your investment.
Full 10-K form ▸
|
|
| related documents |
| 924717--12/14/2006--SURMODICS_INC |
| 887227--6/13/2007--CHOLESTECH_CORPORATION |
| 1018952--3/16/2006--KOS_PHARMACEUTICALS_INC |
| 891288--3/30/2006--QUESTCOR_PHARMACEUTICALS_INC |
| 723889--3/30/2006--MFIC_CORP |
| 46080--2/27/2008--HASBRO_INC |
| 18937--2/26/2008--CERADYNE_INC |
| 1004960--3/13/2006--CONNETICS_CORP |
| 8146--4/13/2009--ASTRO_MED_INC_/NEW/ |
| 811641--3/23/2006--IMMUCELL_CORP_/DE/ |
| 46080--2/25/2009--HASBRO_INC |
| 1004608--3/30/2007--PINNACLE_DATA_SYSTEMS_INC |
| 1104252--3/12/2007--DDI_CORP |
| 720500--12/21/2006--AMTECH_SYSTEMS_INC |
| 842162--3/9/2006--LEAR_CORP |
| 1356949--3/14/2007--Houston_Wire_&_Cable_CO |
| 877212--2/28/2006--ZEBRA_TECHNOLOGIES_CORP/DE |
| 56701--8/20/2007--KOSS_CORP |
| 355999--2/29/2008--UNITED_STATIONERS_INC |
| 355999--2/27/2009--UNITED_STATIONERS_INC |
| 851205--2/14/2008--COGNEX_CORP |
| 862861--3/28/2008--APPLIANCE_RECYCLING_CENTERS_OF_AMERICA_INC_/MN |
| 355999--3/6/2006--UNITED_STATIONERS_INC |
| 355999--3/1/2007--UNITED_STATIONERS_INC |
| 93631--10/24/2008--FREDERICK'S_OF_HOLLYWOOD_GROUP_INC_/NY/ |
| 885245--4/16/2008--BUCKLE_INC |
| 1077688--2/28/2007--HOOKER_FURNITURE_CORP |
| 1311538--6/29/2009--Castle_Brands_Inc |
| 842162--3/17/2009--LEAR_CORP |
| 1001902--2/26/2010--INTEVAC_INC |
|